10 AI News And Ratings on Wall Street’s Radar

7. Schrödinger Inc. (NASDAQ:SDGR)

Number of Hedge Fund Holders: 17

Schrödinger Inc. (NASDAQ:SDGR) utilizes quantum mechanics in medicine and material design to help biopharma companies as well as government labs in their research programs. Its drug discovery programs in various therapeutic areas lower drug development risks by identifying high-value targets backed by clinical validation. Declining computation costs, Schrödinger Inc.’s (NASDAQ:SDGR) protein structure forecasting technology and AI integration are collectively expanding its capabilities to speed up physics simulations and develop technologies like machine-learned force fields for precise molecular property prediction.

On January 24th, KeyBanc hiked Schrödinger Inc.’s (NASDAQ:SDGR) stock price target to $27 from $25 while reiterating an “Overweight” rating. The brokerage is of the view that the company deserves a more premium valuation multiple, given its recurring, high-margin revenue streams and massive internal pipeline of opportunities.